Reversible dementia with parkinsonian features associated with budesonide use.
Prodan
Calin I
CI
Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, USA. calin-prodan@ouhsc.edu
Monnot
Marilee
M
Ross
Elliot D
ED
Coleman
Anton E
AE
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D019819:Budesonide / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D003704:Dementia / Q000139:chemically induced* / Q000175:diagnosis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis*
D000893:Anti-Inflammatory Agents; D019819:Budesonide